W alk into any clinic today and you’ll hear the same concern from people managing diabetes: “Is there something easier and more effective?” That’s where Ozempic steps in. Newly launched in India, this once-weekly injection has become a global sensation for its dual role in blood sugar control and weight management.

But in India, where most people pay for medicines out of their own pocket—the biggest question isn’t about how it works, but whether it fits into a monthly budget.

Ozempic mimics the hormone GLP-1 (glucagon-like peptide-1), helping the body release insulin, slow digestion and reduce appetite.

While its Indian approval is specifically for diabetes management, its wider global use for weight-linked conditions has pushed up demand. In several countries, semaglutide medicines ha

See Full Page